NHS trusts are being offered a free trial of an app aimed to help prevent hospital-acquired acute kidney injury and pneumonia.
The Compass app, provides NHS clinical staff with a tool for accurately assessing each patient’s risk of developing the conditions in hospital, so that appropriate action can be taken to help prevent the numbers of AKI and HAP cases.
A study by researchers at University Hospital Southampton NHS Foundation Trust, carried out between March and May 2020, found that AKI was present in 31 per cent of Covid-19 hospital patients, and that AKI was associated with 27 per cent of admissions to ICU. The findings also showed that 44 per cent of Covid-19 patients with AKI died, compared to 19 per cent of Covid-19 patients without AKI.
The company behind the Compass app, C2-Ai, says that data from hospitals around the world already using the Compass system shows hospitals can expect to reduce instances of hospital-acquired AKI and pneumonia by 50-60 per cent.
Steve Barnett, vice president of global engagement at C2-Ai, said: “We’re offering hospitals a chance to trial the technology because we want NHS trusts to be as prepared as they can be to treat patients. With rising numbers of Covid-19 cases and potential winter flu disruption, hospital bed capacity on wards and in intensive care units is vital. We want to help hospitals save lives, free up clinicians’ time and save money on treating harmful conditions that are avoidable.”
“By risk-assessing patients on admission for their risks of acquiring hospital-acquired acute kidney injury and pneumonia, the system supports clinicians with specific advice on care tailored to each patient – reducing the number of patients acquiring the conditions and so preventing harm and saving lives. Information from hospital finance teams show our app saves them thirty times the amount they would otherwise have to spend on extra bed days and ICU resources for AKI and HAP.”
